IRD · Opus Genetics, Inc.

Summary

Opus Genetics, Inc. (IRD) filed a Form 8-K on March 10, 2026, under Item 2.02 with Exhibit 99.1 press release furnished, announcing results of operations. The filing includes historical analyst consensus EPS data and forward consensus estimates for 2027.

Key takeaways

• Filing under Item 2.02 Results of Operations and Item 9.01 Exhibits
• Exhibit 99.1: Press Release dated 2026-03-10
• 2025-11-12 EPS $-0.12 vs est $-0.14
• 2025-08-13 EPS $-0.12 vs est $-0.25
• 2025-05-15 EPS $-0.32 vs est $-0.34
• Forward 2027-03-31 consensus EPS $-0.13
• Forward 2027-06-30 consensus EPS $-0.13